|
|
|
Bone marrow stem cells transplanted into mice with a diabetes-like illness raise the animals’ insulin to near-normal levels and significantly reduce their blood sugar levels, according to a report in the July issue of Nature Biotechnology. Mickie Bhatia and colleagues found that the transplanted stem cells did not produce insulin themselves but stimulated regeneration of the animals’ own pancreatic cells.
While the approach shows promise, it has not yet been studied in humans, and further research will be needed before it can be considered as a therapy for people with diabetes. Author contact: Mickie Bhatia
Robarts Research Institute
London, Ontario
Canada
Tel: +1 519 663 5777 Ext. 1-34166
E-mail: mbhatia@robarts.ca Also available online. (C) Nature Biotechnology press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|